Skip to menu Skip to content Skip to footer
Associate Professor

John Cole

Email: 

Overview

Availability

Associate Professor John Cole is:
Available for supervision

Works

Search Professor John Cole’s works on UQ eSpace

33 works between 1986 and 2022

21 - 33 of 33 works

1990

Journal Article

The effect in vitro of 2'-deoxycytidine on the metabolism and cytotoxicity of 2',3'-dideoxycytidine

Bhalla, K. N., Li, G. R., Grant, S., Cole, J. T., Maclaughlin, W. W. and Volsky, D. J. (1990). The effect in vitro of 2'-deoxycytidine on the metabolism and cytotoxicity of 2',3'-dideoxycytidine. Aids, 4 (5), 427-431. doi: 10.1097/00002030-199005000-00008

The effect in vitro of 2'-deoxycytidine on the metabolism and cytotoxicity of 2',3'-dideoxycytidine

1990

Journal Article

Acute myelomonocytic leukemia presenting as a benign-appearing cutaneous eruption

Horlick, Howard P., Silvers, David N., Knobler, Elizabeth H. and Cole, John T. (1990). Acute myelomonocytic leukemia presenting as a benign-appearing cutaneous eruption. Archives of Dermatology, 126 (5), 653-656. doi: 10.1001/archderm.126.5.653

Acute myelomonocytic leukemia presenting as a benign-appearing cutaneous eruption

1989

Journal Article

2'-Deoxycytidine protects normal human bone marrow progenitor cells in vitro against the cytotoxicity of 3'-azido-3'-deoxythymidine with preservation of antiretroviral activity

Bhalla, K., Birkhofer, M., Li, G. R., Grant, S., Maclaughlin, W., Cole, J., Graham, G. and Volsky, D. J. (1989). 2'-Deoxycytidine protects normal human bone marrow progenitor cells in vitro against the cytotoxicity of 3'-azido-3'-deoxythymidine with preservation of antiretroviral activity. Blood, 74 (6), 1923-1928.

2'-Deoxycytidine protects normal human bone marrow progenitor cells in vitro against the cytotoxicity of 3'-azido-3'-deoxythymidine with preservation of antiretroviral activity

1988

Journal Article

Phase I clinical and pharmacologic study of deoxycytidine

Bhalla, K., Birkhofer, M., Grant, S., Baker, M., Maclaughlin, W., Cole, J. and Graham, G. (1988). Phase I clinical and pharmacologic study of deoxycytidine. Leukemia, 2 (10), 709-710.

Phase I clinical and pharmacologic study of deoxycytidine

1988

Conference Publication

Phase-I Study of Deoxycytidine Administered as a 120 Hour Continuous Intravenous-Infusion

Bhalla, K., Grant, S., Maclaughlin, W., Cole, J., Birkhofer, M., Kappel, B., Kritz, A. and Graham, G. (1988). Phase-I Study of Deoxycytidine Administered as a 120 Hour Continuous Intravenous-Infusion. -, -, -. PHILADELPHIA: AMER ASSOC CANCER RESEARCH.

Phase-I Study of Deoxycytidine Administered as a 120 Hour Continuous Intravenous-Infusion

1988

Conference Publication

Continuously Administered 2',2'-Difluorodeoxycytidine (Dfdc) and Deoxycytidine (Dcyd) - a Potentially Selective Cyto-Toxic Regimen Toward Human-Leukemic Myeloid Progenitors in Culture

Bhalla, K., Maclaughlin, W., Cole, J., Arlin, Z., Birkhofer, M. and Graham, G. (1988). Continuously Administered 2',2'-Difluorodeoxycytidine (Dfdc) and Deoxycytidine (Dcyd) - a Potentially Selective Cyto-Toxic Regimen Toward Human-Leukemic Myeloid Progenitors in Culture. -, -, -. PHILADELPHIA: AMER ASSOC CANCER RESEARCH.

Continuously Administered 2',2'-Difluorodeoxycytidine (Dfdc) and Deoxycytidine (Dcyd) - a Potentially Selective Cyto-Toxic Regimen Toward Human-Leukemic Myeloid Progenitors in Culture

1987

Journal Article

Effect of deoxycytidine on the metabolism and cytotoxicity of 5-aza-2'-deoxycytidine and arabinosyl 5-azacytosine in normal and leukemic human myeloid progenitor cells

Bhalla, K., Cole, J., Maclaughlin, W., Arlin, Z., Baker, M., Graham, G. and Grant, S. (1987). Effect of deoxycytidine on the metabolism and cytotoxicity of 5-aza-2'-deoxycytidine and arabinosyl 5-azacytosine in normal and leukemic human myeloid progenitor cells. Leukemia, 1 (12), 814-819.

Effect of deoxycytidine on the metabolism and cytotoxicity of 5-aza-2'-deoxycytidine and arabinosyl 5-azacytosine in normal and leukemic human myeloid progenitor cells

1987

Journal Article

Deoxycytidine preferentially protects normal versus leukemic myeloid progenitor cells from cytosine arabinoside-mediated cytotoxicity

Bhalla, K., Maclaughlin, W., Cole, J., Arlin, Z., Baker, M., Graham, G. and Grant, S. (1987). Deoxycytidine preferentially protects normal versus leukemic myeloid progenitor cells from cytosine arabinoside-mediated cytotoxicity. Blood, 70 (2), 568-571.

Deoxycytidine preferentially protects normal versus leukemic myeloid progenitor cells from cytosine arabinoside-mediated cytotoxicity

1987

Conference Publication

High-Dose of Deoxycytidine Analogs and Deoxycytidine - a Potentially Selective Cytotoxic Regimen Against Breast-Cancer Cells (47D) in Culture

MacLaughlin, W., Cole, J., Grant, S. and Bhalla, K. (1987). High-Dose of Deoxycytidine Analogs and Deoxycytidine - a Potentially Selective Cytotoxic Regimen Against Breast-Cancer Cells (47D) in Culture. -, -, -. PHILADELPHIA: AMER ASSOC CANCER RESEARCH.

High-Dose of Deoxycytidine Analogs and Deoxycytidine - a Potentially Selective Cytotoxic Regimen Against Breast-Cancer Cells (47D) in Culture

1987

Conference Publication

Mechanism Underlying the Selective Cytotoxicity of High-Dose Ara-C and Deoxycytidine Toward Human-Leukemic Myeloid Progenitor Cells

Bhalla, K., Maclaughlin, W., Cole, J., Arlin, Z., Baker, M., Graham, G. and Grant, S. (1987). Mechanism Underlying the Selective Cytotoxicity of High-Dose Ara-C and Deoxycytidine Toward Human-Leukemic Myeloid Progenitor Cells. -, -, -. PHILADELPHIA: AMER ASSOC CANCER RESEARCH.

Mechanism Underlying the Selective Cytotoxicity of High-Dose Ara-C and Deoxycytidine Toward Human-Leukemic Myeloid Progenitor Cells

1986

Journal Article

Deoxycytidine stimulates the in vitro growth of normal CFU-GM and reverses the negative regulatory effects of acidic isoferritin and prostaglandin E1

Bhalla, K., Cole, J., Maclaughlin, W., Baker, M., Arlin, Z., Graham, G. and Grant, S. (1986). Deoxycytidine stimulates the in vitro growth of normal CFU-GM and reverses the negative regulatory effects of acidic isoferritin and prostaglandin E1. Blood, 68 (5), 1136-1141.

Deoxycytidine stimulates the in vitro growth of normal CFU-GM and reverses the negative regulatory effects of acidic isoferritin and prostaglandin E1

1986

Conference Publication

Differential Reversal of Deoxycytidine Analog Mediated Cytotoxicity by Deoxycytidine in Cultured Normal and Leukemic Myeloid Progenitors

MacLaughlin, W., Bhalla, K., Cole, J. and Grant, S. (1986). Differential Reversal of Deoxycytidine Analog Mediated Cytotoxicity by Deoxycytidine in Cultured Normal and Leukemic Myeloid Progenitors. -, -, -. THOROFARE: SLACK INC.

Differential Reversal of Deoxycytidine Analog Mediated Cytotoxicity by Deoxycytidine in Cultured Normal and Leukemic Myeloid Progenitors

1986

Conference Publication

Continuously Administered High-Dose Ara-C and Deoxycytidine - a Potentially Selective Cytotoxic Regimen Toward Human-Leukemic Myeloid Progenitors in Culture

Bhalla, K., Maclaughlin, W., Cole, J., Arlin, Z., Baker, M., Graham, G. and Grant, S. (1986). Continuously Administered High-Dose Ara-C and Deoxycytidine - a Potentially Selective Cytotoxic Regimen Toward Human-Leukemic Myeloid Progenitors in Culture. -, -, -. PHILADELPHIA: AMER ASSOC CANCER RESEARCH.

Continuously Administered High-Dose Ara-C and Deoxycytidine - a Potentially Selective Cytotoxic Regimen Toward Human-Leukemic Myeloid Progenitors in Culture

Supervision

Availability

Associate Professor John Cole is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Media

Enquiries

For media enquiries about Associate Professor John Cole's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au